{"disease":{"id":"liver-cancer-of-primary-resectable","name":"liver cancer of primary resectable"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05701436","title":"Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":144,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT06214533","title":"Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasive Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}